NLRP3 and liver disorder: Increasing studies have indicated that the aberration of the NLRP3 inflammasome is implicated in liver diseases, including drug-induced liver injury (DILI), hepatocellular carcinoma (HCC), cholestatic liver injury (CLI), and autoimmune hepatitis (AIH) (Neumann et al., 2018).